Recent research has suggested that antibodies may hold the key to helping prevent and treat Alzheimer’s disease. Scientists at the University of Nottingham in the UK have developed a new approach that uses antibodies to target the blood-brain barrier (BBB), a protective layer of cells that separates the brain from the bloodstream and is known to be impaired in Alzheimer’s disease. The approach has the potential to improve the delivery of drugs to the brain, a critical step in treating the disease. The team’s findings have been published in the journal Scientific Reports.

Read Full Article Here

source: Phys.org